{"id":4077,"date":"2023-07-10T15:41:22","date_gmt":"2023-07-10T15:41:22","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=4077"},"modified":"2023-07-15T15:48:00","modified_gmt":"2023-07-15T15:48:00","slug":"west-african-journal-of-pharmacy-2021-32-1-74-85","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2021-32-1-74-85\/","title":{"rendered":"West African Journal of Pharmacy (2021) 32 (1) 74 &#8211; 85"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4077\" class=\"elementor elementor-4077\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-46751f27 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"46751f27\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6d4df51d\" data-id=\"6d4df51d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-143c79bc elementor-widget elementor-widget-text-editor\" data-id=\"143c79bc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: center;\"><b>Schizophrenic symptoms resolution and its predictors among people living with schizophrenia receiving inpatient\u00a0<\/b><b style=\"font-size: 19px; color: var( --e-global-color-text );\">treatment in a Nigerian neuropsychiatric hospital<\/b><\/p><p style=\"text-align: center;\"><b>\u00a0<\/b><\/p><p style=\"text-align: center;\">Aminu A. Biambo , Aliyu Samaila , Nuruddeen Usman , Ummulkulsum D. Abubakar , Badamasi S. Nuhu ,\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Sadiq A. Hussaini , Saida S. Mansur , Adebayo S. Adebisi<\/span><\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">1Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences,\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Usmanu Danfodiyo University Sokoto, Nigeria<\/span><\/p><p style=\"text-align: center;\">2<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Ibrahim Badamasi Babangida Specialists Hospital Minna, Nigeria<\/span><\/p><p style=\"text-align: center;\">3<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Federal Neuropsychiatric Hospital, Kware &#8211; Sokoto, Nigeria<\/span><\/p><p style=\"text-align: center;\"><span style=\"font-size: 19px; color: var( --e-global-color-text );\">\u00a0<\/span><\/p><p style=\"text-align: center;\"><span style=\"font-size: 19px; color: var( --e-global-color-text );\">Corresponding author: Aminu A. Bia<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">mbo<\/span><\/p><p style=\"text-align: center;\">Email: biambo.aminu@udusok.edu.ng; Phone: +2348065268340<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-18408d6f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"18408d6f\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d6756f1\" data-id=\"d6756f1\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-40b65c81 elementor-widget elementor-widget-heading\" data-id=\"40b65c81\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4672b7a7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4672b7a7\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6bb6c762\" data-id=\"6bb6c762\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2aabd2ab elementor-widget elementor-widget-text-editor\" data-id=\"2aabd2ab\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: justify;\"><b>Background:<\/b> Keeping track of the therapeutic response and its predictors among schizophrenic patients requires\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">periodic evaluation of their symptoms.<\/span><\/p><p style=\"text-align: justify;\"><b>Objectives:<\/b> To evaluate the resolution of symptoms and its predictors among schizophrenic inpatients receiving\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">treatment in Federal Neuropsychiatric Hospital, Kware &#8211; Sokoto.<\/span><\/p><p style=\"text-align: justify;\"><b>Methods:<\/b> Using a prospective longitudinal design, all the 172 patients admitted between June and November\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">2017 who met the inclusion criteria for this study were evaluated for psychiatric symptoms. The instrument used\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">was the validated Positive and Negative Syndrome Scale. Data were collected at different time intervals and\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">analysed for descriptive, ANOVA, and logistic regression statistics at p&lt;0.05.<\/span><\/p><p style=\"text-align: justify;\"><b>Results:<\/b> The average age of the patients was 35.3\u00b112.7 years. Their baseline overall symptoms score was\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">73.0\u00b124.6. The percentage of symptoms resolution after 2-weeks and 4-weeks of treatment were, 46.2\u00b116.0%\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">and 71.0\u00b114.7%, respectively. After the 4-weeks, 97(56.4%) of the patients had good symptoms resolution\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">(&gt;70%). Multivariate logistic regression model shows that patients with predominantly negative symptoms had\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">their odds of having good symptom resolution significantly reduced by 53.5% (OR=0.465, p=0.030) while every\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">unit increase in baseline score significantly decreases the odds by 2% (OR=0.980, p=0.008). The difference in type\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">or class of neuroleptic agent had no significant effect in overall symptoms resolution after 4-weeks.<\/span><\/p><p style=\"text-align: justify;\"><b>Conclusion:<\/b> Most of the patients achieved good symptom resolution after four weeks of therapy. Negative\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">symptoms and higher disease severity at baseline are the predictors of poor symptoms resolution. Caregivers\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">should consider this finding in designing a care plan for schizophrenic patients to improve their outcomes.<\/span><\/p><p style=\"text-align: justify;\"><b>KeyWords:<\/b> Pharmacotherapy; predictors; schizophrenia; symptoms resolution; symptom rating scale; treatment<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-77ed6ce elementor-align-right elementor-widget elementor-widget-button\" data-id=\"77ed6ce\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/wapcpharm.org\/journal\/wp-conten\/t\/uploads\/2023\/07\/Chapter-7_compressed-1.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Download <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Schizophrenic symptoms resolution and its predictors among people living with schizophrenia receiving inpatient\u00a0treatment in a Nigerian neuropsychiatric hospital \u00a0 Aminu A. Biambo , Aliyu Samaila , Nuruddeen Usman , Ummulkulsum D. Abubakar , Badamasi S. Nuhu ,\u00a0Sadiq A. Hussaini , Saida S. Mansur , Adebayo S. Adebisi \u00a0 1Department of Clinical Pharmacy and Pharmacy Practice, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[229],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4077"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=4077"}],"version-history":[{"count":4,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4077\/revisions"}],"predecessor-version":[{"id":4083,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4077\/revisions\/4083"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=4077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=4077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=4077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}